SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) purchased 15K shares of VISTAGEN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.1K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2019ACC: 0001415889-19-001357
DirectorOfficer· PRES./CHIEF SCIENTIFIC OFFICER
Since Aug 2018
+15K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+15K
Price / share
$0.34
Trade value
$5.10K
% of position
New position
11/20/2019
0.00→15K
Total
Net shares
+15K
Net value
$5.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/20/2019 | P · Purchase | +15K | $0.34 | $5.10K | New position | 0.00 | 15K |
| Total | +15K | $5.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned62.72K
Total
62.72K direct62.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 62.72K | Direct |
| Total | 62.72K | 62.72K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported